Entropy Technologies LP Acquires 24,801 Shares of Ventas, Inc. $VTR

Entropy Technologies LP grew its holdings in shares of Ventas, Inc. (NYSE:VTR) by 30.9% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 104,997 shares of the real estate investment trust’s stock after purchasing an additional 24,801 shares during the period. Entropy Technologies LP’s holdings in Ventas were worth $7,349,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in VTR. Cloud Capital Management LLC acquired a new stake in Ventas during the third quarter worth approximately $25,000. True Wealth Design LLC raised its holdings in Ventas by 1,557.7% in the 3rd quarter. True Wealth Design LLC now owns 431 shares of the real estate investment trust’s stock valued at $30,000 after acquiring an additional 405 shares in the last quarter. ORG Partners LLC lifted its position in shares of Ventas by 76.1% during the 3rd quarter. ORG Partners LLC now owns 456 shares of the real estate investment trust’s stock valued at $32,000 after acquiring an additional 197 shares during the period. Wilmington Savings Fund Society FSB lifted its position in shares of Ventas by 65.5% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 455 shares of the real estate investment trust’s stock valued at $32,000 after acquiring an additional 180 shares during the period. Finally, Elevation Point Wealth Partners LLC acquired a new stake in shares of Ventas during the 2nd quarter worth $35,000. 94.18% of the stock is owned by institutional investors.

Ventas Price Performance

Shares of VTR stock opened at $86.14 on Friday. The business has a fifty day simple moving average of $81.27 and a 200 day simple moving average of $76.19. The company has a market cap of $40.91 billion, a P/E ratio of 159.51, a P/E/G ratio of 2.09 and a beta of 0.73. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 1.03. Ventas, Inc. has a twelve month low of $60.15 and a twelve month high of $87.87.

Ventas (NYSE:VTR) last released its earnings results on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.74). The business had revenue of ($1,229.71) million during the quarter, compared to the consensus estimate of $1.53 billion. Ventas had a net margin of 4.31% and a return on equity of 2.09%. The business’s revenue was up 21.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.81 EPS. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. On average, sell-side analysts forecast that Ventas, Inc. will post 3.4 EPS for the current fiscal year.

Ventas Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, April 16th. Investors of record on Tuesday, March 31st will be issued a dividend of $0.52 per share. This is a boost from Ventas’s previous quarterly dividend of $0.48. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $2.08 annualized dividend and a dividend yield of 2.4%. Ventas’s payout ratio is presently 355.56%.

Insider Buying and Selling

In other Ventas news, EVP Carey S. Roberts sold 35,532 shares of the firm’s stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $85.00, for a total value of $3,020,220.00. Following the sale, the executive vice president owned 72,755 shares in the company, valued at $6,184,175. This trade represents a 32.81% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CEO Debra A. Cafaro sold 10,322 shares of the business’s stock in a transaction on Monday, February 2nd. The stock was sold at an average price of $77.66, for a total transaction of $801,606.52. Following the sale, the chief executive officer directly owned 1,114,034 shares in the company, valued at approximately $86,515,880.44. The trade was a 0.92% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 86,106 shares of company stock worth $6,931,397 in the last three months. 0.80% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of research analysts recently commented on VTR shares. Wells Fargo & Company raised their price target on Ventas from $80.00 to $88.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 25th. The Goldman Sachs Group reiterated a “buy” rating and set a $100.00 price objective on shares of Ventas in a research note on Monday, February 9th. Jefferies Financial Group reissued a “buy” rating and issued a $93.00 target price on shares of Ventas in a report on Monday, December 15th. Mizuho boosted their target price on shares of Ventas from $87.00 to $94.00 and gave the company an “outperform” rating in a research report on Wednesday, March 4th. Finally, Citigroup upped their price target on shares of Ventas from $88.00 to $96.00 and gave the stock a “buy” rating in a report on Wednesday, February 11th. Thirteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Ventas has a consensus rating of “Moderate Buy” and an average target price of $89.00.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.